Clinical Trial Update: The Optimal Radioimmunotherapy Combinations for Advanced TNBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on optimal radioimmunotherapy combinations for advanced triple-negative breast cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Triple-Negative Breast Cancer (TNBC) | Phase 2 | Status: RECRUITING